{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T13:00:30Z","timestamp":1784206830873,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jaadinternational.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD International"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jdin.2024.09.001","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T03:24:51Z","timestamp":1727839491000},"page":"69-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Efficacy and safety of guselkumab in European patients with palmoplantar pustulosis: A multi-center, single-arm clinical trial (GAP study)"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5594-7192","authenticated-orcid":false,"given":"Dagmar","family":"Wilsmann-Theis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selina","family":"Patt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Pinter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Gerdes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Magnolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"N\u00e9meth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Augustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Staubach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansgar","family":"Weyergraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"H\u00fcffmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Wolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sabat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rotraut","family":"M\u00f6\u00dfner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jdin.2024.09.001_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5070\/D3234034627","article-title":"Palmoplantar pustulosis - a cross-sectional analysis in Germany","volume":"23","author":"Wilsmann-Theis","year":"2017","journal-title":"Dermatol Online J"},{"issue":"3","key":"10.1016\/j.jdin.2024.09.001_bib2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s40257-020-00503-5","article-title":"Palmoplantar pustulosis: recent advances in etiopathogenesis and emerging treatments","volume":"21","author":"Misiak-Galazka","year":"2020","journal-title":"Am J Clin Dermatol"},{"issue":"7","key":"10.1016\/j.jdin.2024.09.001_bib3","doi-asserted-by":"crossref","first-page":"e335","DOI":"10.1111\/jdv.14131","article-title":"Psoriasis and palmoplantar pustulosis: an endless debate?","volume":"31","author":"Brunasso","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10275","key":"10.1016\/j.jdin.2024.09.001_bib4","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","article-title":"Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis","volume":"397","author":"Ghoreschi","year":"2021","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jdin.2024.09.001_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155215","article-title":"Based on molecular profiling of gene expression, palmoplantar pustulosis and palmoplantar pustular psoriasis are highly related diseases that appear to Be distinct from psoriasis vulgaris","volume":"11","author":"Bissonnette","year":"2016","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.jdin.2024.09.001_bib6","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1089\/jir.2023.0105","article-title":"Biology of interleukin-17 and novel therapies for hidradenitis Suppurativa","volume":"43","author":"Sabat","year":"2023","journal-title":"J Interferon Cytokine Res"},{"issue":"7","key":"10.1016\/j.jdin.2024.09.001_bib7","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.jid.2019.01.014","article-title":"IL-17 and IL-22 promote keratinocyte stemness in the germinative compartment in psoriasis","volume":"139","author":"Ekman","year":"2019","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.jdin.2024.09.001_bib8","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00109-009-0457-0","article-title":"IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not","volume":"87","author":"Wolk","year":"2009","journal-title":"J Mol Med (Berl)"},{"issue":"1","key":"10.1016\/j.jdin.2024.09.001_bib9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1523-1747.2000.00041.x","article-title":"Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4-induced activation of human keratinocytes","volume":"115","author":"Albanesi","year":"2000","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.jdin.2024.09.001_bib10","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/jid.2010.340","article-title":"Integrative responses to IL-17 and TNF-alpha in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis","volume":"131","author":"Chiricozzi","year":"2011","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.jdin.2024.09.001_bib11","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jdermsci.2021.03.004","article-title":"New fluorescent three-dimensional and deep-imaging technique confirms a direct relationship between the acrosyringium and vesicles\/pustules of palmoplantar pustulosis","volume":"102","author":"Murakami","year":"2021","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jdin.2024.09.001_bib12","article-title":"Associations of inflammatory cytokines with palmoplantar pustulosis: a bidirectional Mendelian randomization study","volume":"11","author":"Liu","year":"2024","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.jdin.2024.09.001_bib13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jdermsci.2017.12.018","article-title":"Increased levels of lipocalin 2 in palmoplantar pustular psoriasis","volume":"90","author":"Wolk","year":"2018","journal-title":"J Dermatol Sci"},{"issue":"2","key":"10.1016\/j.jdin.2024.09.001_bib14","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.3390\/ijms24021276","article-title":"Interleukin-19 levels are increased in palmoplantar pustulosis and reduced following apremilast treatment","volume":"24","author":"Wolk","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jdin.2024.09.001_bib15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/ced.13689","article-title":"Interleukin (IL)-8 and IL-36gamma but not IL-36Ra are related to acrosyringia in pustule formation associated with palmoplantar pustulosis","volume":"44","author":"Xiaoling","year":"2019","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jdin.2024.09.001_bib16","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jaci.2024.05.015","article-title":"A genome-wide meta-analysis of palmoplantar pustulosis implicates T(H)2 responses and cigarette smoking in disease pathogenesis","volume":"154","author":"Hernandez-Cordero","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.jdin.2024.09.001_bib17","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jaci.2022.04.027","article-title":"Single-cell analysis implicates T(H)17-to-T(H)2 cell plasticity in the pathogenesis of palmoplantar pustulosis","volume":"150","author":"McCluskey","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.jdin.2024.09.001_bib18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/ced.14829","article-title":"Clinical characteristics, quality of life and risk factors for severity in palmoplantar pustulosis: a cross-sectional, multicentre study of 263 patients","volume":"47","author":"Sarikaya Solak","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jdin.2024.09.001_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1281685","article-title":"Molecular and functional changes in neutrophilic granulocytes induced by nicotine: a systematic review and critical evaluation","volume":"14","author":"Brembach","year":"2023","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.jdin.2024.09.001_bib20","first-page":"503","article-title":"Drug survival and reasons for drug discontinuation in palmoplantar pustulosis: a retrospective multicenter study","volume":"17","author":"Kromer","year":"2019","journal-title":"J Dtsch Dermatol Ges"},{"issue":"6","key":"10.1016\/j.jdin.2024.09.001_bib21","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1007\/s13555-021-00612-x","article-title":"Pustular psoriasis: a narrative review of recent developments in pathophysiology and therapeutic options","volume":"11","author":"Menter","year":"2021","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"10","key":"10.1016\/j.jdin.2024.09.001_bib22","first-page":"940","article-title":"Etanercept in the treatment of palmoplantar pustulosis","volume":"7","author":"Bissonnette","year":"2008","journal-title":"J Drugs Dermatol"},{"issue":"10","key":"10.1016\/j.jdin.2024.09.001_bib23","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/jdv.12272","article-title":"Increased expression of IL-17A and limited involvement of IL-23 in patients with palmo-plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trial","volume":"28","author":"Bissonnette","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.jdin.2024.09.001_bib24","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaad.2019.01.066","article-title":"Secukinumab for moderate-to-severe palmoplantar pustular psoriasis: results of the 2PRECISE study","volume":"80","author":"Mrowietz","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdin.2024.09.001_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110553","article-title":"Efficacy and safety of biological\u00a0agents to treat patients with palmoplantar pustulosis: a systematic scoping review","volume":"122","author":"Zhang","year":"2023","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"10.1016\/j.jdin.2024.09.001_bib26","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s13555-021-00504-0","article-title":"Spesolimab, an anti-interleukin-36 receptor antibody, in patients with palmoplantar pustulosis: results of a phase IIa, multicenter, double-blind, randomized, placebo-controlled pilot study","volume":"11","author":"Mrowietz","year":"2021","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"10","key":"10.1016\/j.jdin.2024.09.001_bib27","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/jamadermatol.2019.1394","article-title":"Efficacy and safety of guselkumab in Japanese patients with palmoplantar pustulosis: a phase 3 randomized clinical trial","volume":"155","author":"Terui","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.jdin.2024.09.001_bib28","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jamadermatol.2017.5937","article-title":"Efficacy and safety of guselkumab, an anti-interleukin 23 monoclonal antibody, for palmoplantar pustulosis: a randomized clinical trial","volume":"154","author":"Terui","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"12","key":"10.1016\/j.jdin.2024.09.001_bib29","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1111\/1346-8138.16132","article-title":"Sustained efficacy and safety of guselkumab in patients with palmoplantar pustulosis through 1.5 years in a randomized phase 3 study","volume":"48","author":"Okubo","year":"2021","journal-title":"J Dermatol"},{"issue":"4","key":"10.1016\/j.jdin.2024.09.001_bib30","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.jaad.2019.11.040","article-title":"Maintenance of clinical\u00a0response and consistent safety profile with up to 3 years of\u00a0continuous treatment with guselkumab: results\u00a0from\u00a0the\u00a0VOYAGE 1 and VOYAGE 2 trials","volume":"82","author":"Reich","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jdin.2024.09.001_bib31","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00281-019-00742-7","article-title":"T cell pathology in skin inflammation","volume":"41","author":"Sabat","year":"2019","journal-title":"Semin Immunopathol"},{"issue":"11","key":"10.1016\/j.jdin.2024.09.001_bib32","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.4049\/jimmunol.168.11.5397","article-title":"Cutting edge: immune cells as sources and targets of the IL-10 family members?","volume":"168","author":"Wolk","year":"2002","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.jdin.2024.09.001_bib33","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/j.1600-0625.2006.00516.x","article-title":"Interleukin (IL)-19, IL-20 and IL-24 are produced by and act on keratinocytes and are distinct from classical ILs","volume":"15","author":"Kunz","year":"2006","journal-title":"Exp Dermatol"},{"issue":"11","key":"10.1016\/j.jdin.2024.09.001_bib34","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1038\/jid.2014.308","article-title":"IL-19 is a component of the pathogenetic IL-23\/IL-17 cascade in psoriasis","volume":"134","author":"Witte","year":"2014","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.jdin.2024.09.001_bib35","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1084\/jem.168.2.543","article-title":"Lymphokine-mediated regulation of the proliferative response of clones of T helper 1 and T helper 2 cells","volume":"168","author":"Fernandez-Botran","year":"1988","journal-title":"J Exp Med"},{"issue":"21","key":"10.1016\/j.jdin.2024.09.001_bib36","doi-asserted-by":"crossref","first-page":"8011","DOI":"10.3390\/ijms21218011","article-title":"CD4 T helper cell subsets and related human\u00a0immunological disorders","volume":"21","author":"Zhu","year":"2020","journal-title":"Int J Mol Sci"}],"container-title":["JAAD International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328724001524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328724001524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T04:00:19Z","timestamp":1740888019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666328724001524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":36,"alternative-id":["S2666328724001524"],"URL":"https:\/\/doi.org\/10.1016\/j.jdin.2024.09.001","relation":{},"ISSN":["2666-3287"],"issn-type":[{"value":"2666-3287","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of guselkumab in European patients with palmoplantar pustulosis: A multi-center, single-arm clinical trial (GAP study)","name":"articletitle","label":"Article Title"},{"value":"JAAD International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdin.2024.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}